IPO Proceeds Monitoring
Monitoring Agency Flags Deviations in IPO Proceeds Utilization
CARE Ratings' monitoring report for Stallion India Fluorochemicals (quarter ended Mar 31, 2026) flags material deviations in IPO proceeds use: excess issue expenses of Rs.3.99 crore, excess working-capital use of Rs.3.71 crore, delays in capex funding, fund commingling and shareholder approval pending.


